On Cancer

Filter by Tag

Pictured: Jedd Wolchok and James Allison

In the News

The New Yorker Features Immune Therapy Work of Memorial Sloan-Kettering Researchers

By Media Staff | Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Tags: Research; Immunotherapy; Immunology

Video

Meet Prostate Cancer Surgeon James Eastham

By Memorial Sloan-Kettering | Monday, April 16, 2012

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Tags: Cancer Care; Surgery; Prostate Cancer

Patient Story

Read Bruce’s Story about Bone Cancer

By Memorial Sloan-Kettering | Monday, April 9, 2012

A routine blood test led to a diagnosis of bone cancer for Bruce, an otherwise healthy 43-year-old writer. Surgeons at Memorial Sloan-Kettering removed his cancer and saved his leg, giving him the chance to resume his career as “the writer who walks.”

Tags: Cancer Care; Bone Cancer; Surgery

In the Lab

Study Points the Way for Future Therapy to Revive a Damaged Immune System

By Eva Kiesler, PhD, Science Writer/Editor | Friday, April 6, 2012

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Tags: Blood & Marrow Stem Cell Transplantation; Lab Research; Research; Drug Discovery; Immunology

Video

Meet Surgeon Yuman Fong

By Memorial Sloan-Kettering | Thursday, April 5, 2012

Yuman Fong, Memorial Sloan-Kettering’s Vice Chair of Technology Development and a surgeon who treats patients with liver, bile duct, gallbladder, and pancreas diseases, talks about surgical advances that improve outcomes for patients.

Tags: Cancer Care; Surgery; Gallbladder & Bile Duct Cancers; Liver Cancer; Pancreatic Cancer

Pictured: American Association of Cancer Research Annual Meeting 2012

Announcement

Memorial Sloan-Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored

By Media Staff | Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Tags: Cancer Care; Research; Personalized Medicine; Brain Tumors; Chronic Myelogenous Leukemia; Prostate Cancer

Q&A

Memorial Sloan-Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

By Memorial Sloan-Kettering | Monday, March 26, 2012

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

Tags: Blood & Marrow Stem Cell Transplantation; Cancer Care

In the O.R.

Patient Experience Improves with New Collaborative Approach to Pinpoint and Remove Small Breast Cancers

By Esther Napolitano, BS and Allyson Collins, MS
Friday, March 16, 2012

Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Tags: Cancer Care; Clinical Research; Medical Technology; Surgery; Breast Cancer

In the Lab

Genetic Profiling Could Help Doctors Make More-Accurate Leukemia Prognoses

By Jim Stallard, MA, Writer/Editor | Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Tags: Cancer Biology; Lab Research; Research; Acute Myelogenous Leukemia; Cancer Genetics; Pediatric Leukemias; Personalized Medicine; Leukemias

Q&A

Surgery’s Vital Role in Treating Cancer

By Memorial Sloan-Kettering | Monday, March 12, 2012

Department of Surgery Chair Peter T. Scardino reflects on the expanding role of surgery at an institution devoted to caring for people with cancer.

Tags: Cancer Care; Surgery

In the Clinic

Rare Medical Phenomenon: Melanoma Patient’s Tumors Disappear throughout the Body after Radiation of One Tumor

By Media Staff | Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Tags: Research; Clinical Research; Immunotherapy; Radiation Therapy; Immunology; Melanoma

Q&A

Neurosurgeon Mark Bilsky on Stereotactic Radiosurgery for Spine Tumors

By Memorial Sloan-Kettering | Wednesday, February 15, 2012

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan-Kettering.

Tags: Cancer Care; Radiation Therapy; Spine Tumors

In the Clinic

New Treatment Option for People with Advanced Kidney Cancer

By Esther Napolitano, BS, Science Writer/Editor | Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Tags: Research; Targeted Therapy; Kidney Cancer

In the News

Memorial Sloan-Kettering Made Major Contributions to Cancer Advances in 2011

By Julie Grisham, MS, Science Writer/Editor | Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Tags: Cancer Care; Research; Personalized Medicine; Targeted Therapy; Melanoma; Ovarian Cancer; Prostate Cancer

Pictured: Charles Sawyers & Howard Scher

In the News

New Medical Strides against Prostate Cancer

By Media Staff | Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Tags: Research; Drug Discovery; Targeted Therapy; Prostate Cancer